Cationic host defense (antimicrobial) peptides

Current Opinion in Immunology - Tập 18 Số 1 - Trang 24-30 - 2006
Kelly L. Brown1, Robert E. W. Hancock1
1Centre for Microbial Diseases and Immunity Research, University of British Columbia, Vancouver, British Columbia, V6T 1Z4, Canada

Tóm tắt

Từ khóa


Tài liệu tham khảo

Hancock, 2000, The role of cationic antimicrobial peptides in innate host defences, Trends Microbiol, 8, 402, 10.1016/S0966-842X(00)01823-0

Hancock, 2002, Role of membranes in the activities of antimicrobial cationic peptides, FEMS Microbiol Lett, 206, 143, 10.1111/j.1574-6968.2002.tb11000.x

Yang, 2002, Mammalian defensins in immunity: more than just microbicidal, Trends Immunol, 23, 291, 10.1016/S1471-4906(02)02246-9

Yang, 2004, Multiple roles of antimicrobial defensins, cathelicidins and eosinophil-derived neurotoxin in host defense, Annu Rev Immunol, 22, 181, 10.1146/annurev.immunol.22.012703.104603

Zasloff, 2002, Antimicrobial peptides of multicellular organisms, Nature, 415, 389, 10.1038/415389a

Uzzell, 2003, Hagfish intestinal antimicrobial peptides are ancient cathelicidins, Peptides, 24, 1655, 10.1016/j.peptides.2003.08.024

Heilborn, 2005, Antimicrobial protein hCAP18/LL-37 is highly expressed in breast cancer and is a putative growth factor for epithelial cells, Int J Cancer, 114, 713, 10.1002/ijc.20795

Islam, 2001, Downregulation of bactericidal peptides in enteric infections: a novel immune escape mechanism with bacterial DNA as a potential regulator, Nat Med, 7, 180, 10.1038/84627

Duits, 2002, Expression of β-defensin 1 and 2 mRNA by human monocytes, macrophages and dendritic cells, Immunology, 106, 517, 10.1046/j.1365-2567.2002.01430.x

Fang, 2003, Differential expression of α- and β-defensins in human peripheral blood, Eur J Clin Invest, 33, 82, 10.1046/j.1365-2362.2003.01076.x

Harder, 2001, Isolation and characterization of human β-defensin-3, a novel human inducible peptide antibiotic, J Biol Chem, 276, 5707, 10.1074/jbc.M008557200

Harder, 2004, Differential gene induction of human beta-defensins (hBD-1, -2, -3, and -4) in keratinocytes is inhibited by retinoic acid, J Invest Dermatol, 123, 522, 10.1111/j.0022-202X.2004.23234.x

Wolk, 2004, IL-22 increases the innate immunity of tissues, Immunity, 21, 241, 10.1016/j.immuni.2004.07.007

Vora, 2004, Beta-defensin-2 expression is regulated by TLR signaling in intestinal epithelial cells, J Immunol, 173, 5398, 10.4049/jimmunol.173.9.5398

Schaefer, 2005, Innate immunity in the human female reproductive tract: antiviral response of uterine epithelial cells to the TLR3 agonist poly(I:C), J Immunol, 174, 992, 10.4049/jimmunol.174.2.992

Proud, 2004, Human rhinovirus infection induces airway epithelial cell production of human beta-defensin 2 both in vitro and in vivo, J Immunol, 172, 4637, 10.4049/jimmunol.172.7.4637

Platz, 2004, Microbial DNA induces a host defense reaction of human respiratory epithelial cells, J Immunol, 173, 1219, 10.4049/jimmunol.173.2.1219

Gudmundsson, 1996, The human gene FALL-39 and processing of the cathelin precursor to the antibacterial peptide LL-37 in granulocytes, Eur J Biochem, 238, 325, 10.1111/j.1432-1033.1996.0325z.x

Tomasinsig, 2005, The cathelicidins — structure, function and evolution, Curr Protein Pept Sci, 6, 23, 10.2174/1389203053027520

Zhao, 1995, Structures of genes for two cathelin-associated antimicrobial peptides: prophenin-2 and PR-39, FEBS Lett, 376, 130, 10.1016/0014-5793(95)01237-3

Liu, 2003, By IL-1 signaling, monocyte-derived cells dramatically enhance the epidermal antimicrobial response to lipopolysaccharide, J Immunol, 170, 575, 10.4049/jimmunol.170.1.575

Hertz, 2003, Activation of Toll-like receptor 2 on human tracheobronchial epithelial cells induces the antimicrobial peptide human defensin-2, J Immunol, 171, 6820, 10.4049/jimmunol.171.12.6820

Wang, 2003, Airway epithelia regulate expression of human beta-defensin 2 through Toll-like receptor 2, FASEB J, 17, 1727, 10.1096/fj.02-0616fje

Frohm Nilsson, 1999, The human cationic antimicrobial protein (hCAP18), a peptide antibiotic, is widely expressed in human squamous epithelia and colocalizes with interleukin-6, Infect Immun, 67, 2561, 10.1128/IAI.67.5.2561-2566.1999

Ganz, 1988, Microbicidal/cytotoxic proteins of neutrophils are deficient in two disorders: Chediak-Higashi syndrome and ‘specific’ granule deficiency, J Clin Invest, 82, 552, 10.1172/JCI113631

Putsep, 2002, Deficiency of antibacterial peptides in patients with morbus Kostmann: an observation study, Lancet, 360, 1144, 10.1016/S0140-6736(02)11201-3

Ong, 2002, Endogenous antimicrobial peptides and skin infections in atopic dermatitis, N Engl J Med, 347, 1151, 10.1056/NEJMoa021481

Nomura, 2003, Cytokine milieu of atopic dermatitis, as compared to psoriasis, skin prevents induction of innate immune response genes, J Immunol, 171, 3262, 10.4049/jimmunol.171.6.3262

Harder, 2005, Psoriatic scales: a promising source for the isolation of human skin-derived antimicrobial proteins, J Leukoc Biol, 77, 476, 10.1189/jlb.0704409

Hiratsuka, 2003, Increased concentrations of human beta-defensins in plasma and bronchoalveolar lavage fluid of patients with diffuse panbronchiolitis, Thorax, 58, 425, 10.1136/thorax.58.5.425

Ross, 2004, Increased bronchoalveolar lavage human beta-defensin type 2 in bronchiolitis obliterans syndrome after lung transplantation, Transplantation, 78, 1222, 10.1097/01.TP.0000137265.18491.75

Dorschner, 2001, Cutaneous injury induces the release of cathelicidin anti-microbial peptides active against group A Streptococcus, J Invest Dermatol, 117, 91, 10.1046/j.1523-1747.2001.01340.x

Scott, 2002, The human antimicrobial peptide LL-37 is a multifunctional modulator of innate immune responses, J Immunol, 169, 3883, 10.4049/jimmunol.169.7.3883

Fukumoto, 2005, Effect of antibacterial cathelicidin peptide CAP18/LL-37 on sepsis in neonatal rats, Pediatr Surg Int, 21, 20, 10.1007/s00383-004-1256-x

Giacometti, 2004, Cathelicidin peptide sheep myeloid antimicrobial peptide-29 prevents endotoxin-induced mortality in rat models of septic shock, Am J Respir Crit Care Med, 169, 187, 10.1164/rccm.200307-971OC

Moser, 2002, β-Defensin 1 contributes to pulmonary innate immunity in mice, Infect Immun, 70, 3068, 10.1128/IAI.70.6.3068-3072.2002

Rosenberger, 2004, Interplay between antibacterial effectors: a macrophage antimicrobial peptide impairs intracellular Salmonella replication, Proc Natl Acad Sci USA, 101, 2422, 10.1073/pnas.0304455101

Iimura, 2005, Cathelicidin mediates innate intestinal defense against colonization with epithelial adherent bacterial pathogens, J Immunol, 174, 4901, 10.4049/jimmunol.174.8.4901

Nizet, 2001, Innate antimicrobial peptide protects the skin from invasive bacterial infection, Nature, 414, 454, 10.1038/35106587

Salzman, 2003, Protection against enteric salmonellosis in transgenic mice expressing a human intestinal defensin, Nature, 422, 522, 10.1038/nature01520

Bader, 2003, Regulation of Salmonella typhimurium virulence gene expression by cationic antimicrobial peptides, Mol Microbiol, 50, 219, 10.1046/j.1365-2958.2003.03675.x

Zhang, 2000, Interaction of polyphemusin I and structural analogs with bacterial membranes, lipopolysaccharide, and lipid monolayers, Biochemistry, 39, 14504, 10.1021/bi0011173

Kragol, 2001, The antibacterial peptide pyrrhocoricin inhibits the ATPase actions of DnaK and prevents chaperone-assisted protein folding, Biochemistry, 40, 3016, 10.1021/bi002656a

Patrzykat, 2002, Sublethal concentrations of pleurocidin-derived antimicrobial peptides inhibit macromolecular synthesis in Escherichia coli, Antimicrob Agents Chemother, 46, 605, 10.1128/AAC.46.3.605-614.2002

Hong, 2003, Transcriptional profile of the Escherichia coli response to the antimicrobial insect peptide cecropin A, Antimicrob Agents Chemother, 47, 1, 10.1128/AAC.47.1.1-6.2003

Bowdish, 2005, Impact of LL-37 on anti-infective immunity, J Leukoc Biol, 77, 451, 10.1189/jlb.0704380

Finlay, 2004, Can innate immunity be enhanced to treat infections?, Nat Rev Microbiol, 2, 497, 10.1038/nrmicro908

Hiemstra, 2004, Antimicrobial peptides: mediators of innate immunity as templates for the development of novel anti-infective and immune therapeutics, Curr Pharm Des, 10, 2891, 10.2174/1381612043383566

Selsted, 2005, Mammalian defensins in the antimicrobial immune response, Nat Immunol, 6, 551, 10.1038/ni1206

Salzet, 2002, Antimicrobial peptides are signaling molecules, Trends Immunol, 23, 283, 10.1016/S1471-4906(02)02236-6

Bowdish, 2005, Immunomodulatory activities of small host defense peptides, Antimicrob Agents Chemother, 49, 1727, 10.1128/AAC.49.5.1727-1732.2005

Niyonsaba, 2001, Evaluation of the effects of peptide antibiotics human beta-defensins-1/-2 and LL-37 on histamine release and prostaglandin D(2) production from mast cells, Eur J Immunol, 31, 1066, 10.1002/1521-4141(200104)31:4<1066::AID-IMMU1066>3.0.CO;2-#

Befus, 1999, Neutrophil defensins induce histamine secretion from mast cells: mechanisms of action, J Immunol, 163, 947, 10.4049/jimmunol.163.2.947

Niyonsaba, 2002, A cathelicidin family of human antibacterial peptide LL-37 induces mast cell chemotaxis, Immunology, 106, 20, 10.1046/j.1365-2567.2002.01398.x

Territo, 1989, Monocyte-chemotactic activity of defensins from human neutrophils, J Clin Invest, 84, 2017, 10.1172/JCI114394

Chertov, 1996, Identification of defensin-1, defensin-2, and CAP37/azurocidin as T-cell chemoattractant proteins released from interleukin-8-stimulated neutrophils, J Biol Chem, 271, 2935, 10.1074/jbc.271.6.2935

Yang, 2000, Human neutrophil defensins selectively chemoattract naive T and immature dendritic cells, J Leukoc Biol, 68, 9, 10.1189/jlb.68.1.9

Garcia, 2001, Human beta-defensin 4: a novel inducible peptide with a specific salt-sensitive spectrum of antimicrobial activity, FASEB J, 15, 1819, 10.1096/fj.00-0865fje

Kurosaka, 2005, Mouse cathelin-related antimicrobial peptide chemoattracts leukocytes using formyl peptide receptor-like 1/mouse formyl peptide receptor-like 2 as the receptor and acts as an immune adjuvant, J Immunol, 174, 6257, 10.4049/jimmunol.174.10.6257

Ohgami, 2003, Effect of human cationic antimicrobial protein 18 peptide on endotoxin-induced uveitis in rats, Invest Ophthalmol Vis Sci, 44, 4412, 10.1167/iovs.03-0246

Vallespi, 2000, A Limulus antilipopolysaccharide factor-derived peptide exhibits a new immunological activity with potential applicability in infectious diseases, Clin Diagn Lab Immunol, 7, 669, 10.1128/CDLI.7.4.669-675.2000

Vallespi, 2003, A Limulus anti-LPS factor-derived peptide modulates cytokine gene expression and promotes resolution of bacterial acute infection in mice, Int Immunopharmacol, 3, 247, 10.1016/S1567-5769(02)00277-1

Braff, 2005, Structure-function relationships among human cathelicidin peptides: dissociation of antimicrobial properties from host immunostimulatory activities, J Immunol, 174, 4271, 10.4049/jimmunol.174.7.4271

Davidson, 2004, The cationic antimicrobial peptide LL-37 modulates dendritic cell differentiation and dendritic cell-induced T cell polarization, J Immunol, 172, 1146, 10.4049/jimmunol.172.2.1146

Biragyn, 2002, Toll-like receptor 4-dependent activation of dendritic cells by β-defensin 2, Science, 298, 1025, 10.1126/science.1075565

Mookherjee N, Brown KL, Bowdish DME, Doria S, Falsafi R, Hokamp K, Roche FM, Mu R, Doho GH, Pistolic J et al.: Modulation of the Toll-like receptor-mediated inflammatory response by the endogenous human host defence peptide LL-37. J Immunol 2006, in press.

Murphy, 1993, Defensins are mitogenic for epithelial cells and fibroblasts, J Cell Physiol, 155, 408, 10.1002/jcp.1041550223

Aarbiou, 2002, Human neutrophil defensins induce lung epithelial cell proliferation in vitro, J Leukoc Biol, 72, 167, 10.1189/jlb.72.1.167

Aarbiou, 2004, Neutrophil defensins enhance lung epithelial wound closure and mucin gene expression in vitro, Am J Respir Cell Mol Biol, 30, 193, 10.1165/rcmb.2002-0267OC

Chavakis, 2004, Regulation of neovascularization by human neutrophil peptides (alpha-defensins): a link between inflammation and angiogenesis, FASEB J, 18, 1306, 10.1096/fj.03-1009fje

An, 2005, LL-37 enhances adaptive antitumor immune response in a murine model when genetically fused with M-CSFR (J6-1) DNA vaccine, Leuk Res, 29, 535, 10.1016/j.leukres.2004.11.009

Biragyn, 2002, DNA vaccines encoding human immunodeficiency virus-1 glycoprotein 120 fusions with proinflammatory chemoattractants induce systemic and mucosal immune responses, Blood, 100, 1153, 10.1182/blood-2002-01-0086

Yang, 2000, LL-37, the neutrophil granule- and epithelial cell-derived cathelicidin, utilizes formyl peptide receptor-like 1 (FPRL1) as a receptor to chemoattract human peripheral blood neutrophils, monocytes, and T cells, J Exp Med, 192, 1069, 10.1084/jem.192.7.1069

Niyonsaba, 2002, Epithelial cell-derived human beta-defensin-2 acts as a chemotaxin for mast cells through a pertussis toxin-sensitive and phospholipase C-dependent pathway, Int Immunol, 14, 421, 10.1093/intimm/14.4.421

Tjabringa, 2003, The antimicrobial peptide LL-37 activates innate immunity at the airway epithelial surface by transactivation of the epidermal growth factor receptor, J Immunol, 171, 6690, 10.4049/jimmunol.171.12.6690

Elssner, 2004, A novel P2X7 receptor activator, the human cathelicidin-derived peptide LL37, induces IL-1β processing and release, J Immunol, 172, 4987, 10.4049/jimmunol.172.8.4987

Lau, 2005, Interaction and cellular localization of the human host defense peptide LL-37 with lung epithelial cells, Infect Immun, 73, 583, 10.1128/IAI.73.1.583-591.2005

Bowdish, 2004, The human cationic peptide LL-37 induces activation of the extracellular signal-regulated kinase and p38 kinase pathways in primary human monocytes, J Immunol, 172, 3758, 10.4049/jimmunol.172.6.3758

Chan, 1998, PR-39, a syndecan-inducing antimicrobial peptide, binds and affects p130 (Cas), J Biol Chem, 273, 28978, 10.1074/jbc.273.44.28978

Shi, 1998, The role of protegrins and other elastase-activated polypeptides in the bactericidal properties of porcine inflammatory fluids, Infect Immun, 66, 3611, 10.1128/IAI.66.8.3611-3617.1998

Gao, 2000, Inhibition of ubiquitin-proteasome pathway-mediated IκBα degradation by a naturally occurring antibacterial peptide, J Clin Invest, 106, 439, 10.1172/JCI9826

McPhee, 2005, Design of host defence peptides for antimicrobial and immunity enhancing activities, Comb Chem High Throughput Screen, 8, 257, 10.2174/1386207053764558

Hancock REW, Brown KL, Mookherjee N: Host defence peptides from invertebrates — emerging antimicrobial strategies. Immunobiology 2005, in press.

Zhang, 2004, Cationic antimicrobial peptides — an update, Expert Opin Investig Drugs, 13, 97, 10.1517/13543784.13.2.97